| FDA | Food and Drug Administration |
| EGFR | Epidermal growth factor receptor |
| TKI | Tyrosine kinase inhibitors |
| BTK | Brutons tyrosine kinase |
| JAK | Janus kinase |
| PI3K | Phosphatidylinositol 3 kinase |
| FGFR4 | Fibroblast growth factor receptor-4 |
| FGF19 | Fibroblast growth factor 19 |
| EA | Ethyl acetate |
| DMF | N,N-Dimethylformamide |
| DIPEA | N,N-Diisopropylethylamine |
| ADR | Doxorubicin |
| DMSO | Dimethyl sulfoxide |
| HPLC | High Performance Liquid Chromatography |
| TLC | Thin Layer Chromatography |
| PE | Petroleum ether |
| ESI MS | Electrospray ionization mass spectrometry |
| HRMS | High resolution mass |
| TMS | Tetramethylsilane |
| RPMI 1640 | Revolutions-Per-minute Indicator 1640 |
| DMEM | Dulbecco’s Modified Eagle Medium |
| ELISA | Enzyme-linked immunosorbent assay |